JP2023158617A - Use of anabasine in heating-type non-combustion electronic delivery product, solid flake, and method for producing the same - Google Patents
Use of anabasine in heating-type non-combustion electronic delivery product, solid flake, and method for producing the same Download PDFInfo
- Publication number
- JP2023158617A JP2023158617A JP2022135290A JP2022135290A JP2023158617A JP 2023158617 A JP2023158617 A JP 2023158617A JP 2022135290 A JP2022135290 A JP 2022135290A JP 2022135290 A JP2022135290 A JP 2022135290A JP 2023158617 A JP2023158617 A JP 2023158617A
- Authority
- JP
- Japan
- Prior art keywords
- anabasine
- solid flakes
- essence
- filler
- adhesive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- MTXSIJUGVMTTMU-JTQLQIEISA-N (S)-anabasine Chemical compound N1CCCC[C@H]1C1=CC=CN=C1 MTXSIJUGVMTTMU-JTQLQIEISA-N 0.000 title claims abstract description 104
- 229930014345 anabasine Natural products 0.000 title claims abstract description 103
- 239000007787 solid Substances 0.000 title claims abstract description 65
- 238000004519 manufacturing process Methods 0.000 title claims description 13
- 238000002485 combustion reaction Methods 0.000 title abstract description 20
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 47
- 239000000835 fiber Substances 0.000 claims abstract description 44
- 239000000945 filler Substances 0.000 claims abstract description 43
- 239000000853 adhesive Substances 0.000 claims abstract description 40
- 230000001070 adhesive effect Effects 0.000 claims abstract description 40
- 235000013311 vegetables Nutrition 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 31
- 238000000034 method Methods 0.000 claims abstract description 30
- 230000008569 process Effects 0.000 claims abstract description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 66
- 239000000686 essence Substances 0.000 claims description 62
- 239000000779 smoke Substances 0.000 claims description 41
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 30
- 238000002156 mixing Methods 0.000 claims description 19
- 239000011248 coating agent Substances 0.000 claims description 17
- 238000000576 coating method Methods 0.000 claims description 17
- 239000002994 raw material Substances 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 13
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 11
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 11
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 11
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 11
- 239000001913 cellulose Substances 0.000 claims description 7
- 229920006184 cellulose methylcellulose Polymers 0.000 claims description 7
- 238000005096 rolling process Methods 0.000 claims description 7
- 238000011049 filling Methods 0.000 claims description 6
- 238000007613 slurry method Methods 0.000 claims description 5
- 238000004537 pulping Methods 0.000 claims description 4
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 abstract description 39
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 abstract description 39
- 229960002715 nicotine Drugs 0.000 abstract description 39
- 230000000391 smoking effect Effects 0.000 abstract description 33
- 239000000443 aerosol Substances 0.000 abstract description 25
- 241000208125 Nicotiana Species 0.000 abstract description 8
- 235000002637 Nicotiana tabacum Nutrition 0.000 abstract description 8
- 150000003839 salts Chemical class 0.000 abstract 2
- 241000700159 Rattus Species 0.000 description 30
- 241001465754 Metazoa Species 0.000 description 29
- 238000012360 testing method Methods 0.000 description 26
- 239000003571 electronic cigarette Substances 0.000 description 17
- 241000220223 Fragaria Species 0.000 description 13
- 235000016623 Fragaria vesca Nutrition 0.000 description 13
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 13
- 244000269722 Thea sinensis Species 0.000 description 10
- 235000011187 glycerol Nutrition 0.000 description 10
- 235000009569 green tea Nutrition 0.000 description 10
- 231100000456 subacute toxicity Toxicity 0.000 description 10
- 230000037396 body weight Effects 0.000 description 9
- 235000019505 tobacco product Nutrition 0.000 description 8
- 235000006679 Mentha X verticillata Nutrition 0.000 description 7
- 235000002899 Mentha suaveolens Nutrition 0.000 description 7
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 7
- 229920001131 Pulp (paper) Polymers 0.000 description 7
- 231100000921 acute inhalation toxicity Toxicity 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 230000037406 food intake Effects 0.000 description 6
- 235000012631 food intake Nutrition 0.000 description 6
- 231100000062 no-observed-adverse-effect level Toxicity 0.000 description 6
- XINCECQTMHSORG-UHFFFAOYSA-N Isoamyl isovalerate Chemical compound CC(C)CCOC(=O)CC(C)C XINCECQTMHSORG-UHFFFAOYSA-N 0.000 description 5
- 238000000769 gas chromatography-flame ionisation detection Methods 0.000 description 5
- 230000007794 irritation Effects 0.000 description 5
- 239000013618 particulate matter Substances 0.000 description 5
- 240000007154 Coffea arabica Species 0.000 description 4
- 244000024873 Mentha crispa Species 0.000 description 4
- 235000014749 Mentha crispa Nutrition 0.000 description 4
- 235000019504 cigarettes Nutrition 0.000 description 4
- 235000016213 coffee Nutrition 0.000 description 4
- 235000013353 coffee beverage Nutrition 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 239000002341 toxic gas Substances 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 3
- 230000006978 adaptation Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 2
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 210000001132 alveolar macrophage Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 235000021045 dietary change Nutrition 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 231100000824 inhalation exposure Toxicity 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000001616 monocyte Anatomy 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 231100000122 subacute inhalation toxicity Toxicity 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- BLUGYPPOFIHFJS-UUFHNPECSA-N (2s)-n-[(2s)-1-[[(3r,4s,5s)-3-methoxy-1-[(2s)-2-[(1r,2r)-1-methoxy-2-methyl-3-oxo-3-[[(1s)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]-3-methyl-2-(methylamino)butanamid Chemical compound CN[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H]([C@@H](C)CC)[C@H](OC)CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C=1SC=CN=1)CC1=CC=CC=C1 BLUGYPPOFIHFJS-UUFHNPECSA-N 0.000 description 1
- 208000007934 ACTH-independent macronodular adrenal hyperplasia Diseases 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 238000011887 Necropsy Methods 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 238000013098 chemical test method Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000000266 injurious effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000008263 liquid aerosol Substances 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000003921 particle size analysis Methods 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 239000008249 pharmaceutical aerosol Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B3/00—Preparing tobacco in the factory
- A24B3/14—Forming reconstituted tobacco products, e.g. wrapper materials, sheets, imitation leaves, rods, cakes; Forms of such products
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B3/00—Preparing tobacco in the factory
- A24B3/12—Steaming, curing, or flavouring tobacco
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Manufacture Of Tobacco Products (AREA)
Abstract
Description
本発明は、加熱式非燃焼電子送達製品におけるアナバシンの使用に関するものであり、電子送達製品の分野に属する。 The present invention relates to the use of anabasine in heated, non-combustible electron delivery products and is in the field of electron delivery products.
人々が健康と環境にますます注意を払うにつれて、タバコの有害成分の放出量を効果的に減らすことができる新しいタバコ製品の研究開発が、世界中のタバコ産業の発展の焦点になりつつある。現在、より代表的なものは、加熱式非燃焼タバコ製品(低温巻きタバコとしても知られている)であり、それは特別な加熱源を通してフィラーを加熱し、加熱すると、カットされたタバコのニコチンが揮発して煙を発生させ、喫煙者のニーズに応え、従来の巻きタバコとは異なり、加熱式非燃焼タバコ製品のカットタバコは、燃焼ではなく加熱状態にあるため、従来のタバコの高温燃焼分解によって生成される有害成分が減少し、主流の煙の有害成分を減らし、同時に、電子タバコには本物のタバコの味がないという欠点を克服することもできる。その結果、加熱式非燃焼タバコ製品は、消費者にますます人気がある。 As people pay more and more attention to health and the environment, the research and development of new tobacco products that can effectively reduce the amount of harmful components released by tobacco is becoming the focus of the development of the tobacco industry around the world. Currently, the more typical one is heated non-combustible tobacco products (also known as cold cigarettes), which heat the filler through a special heating source, and when heated, the nicotine in the cut tobacco is released. It volatilizes to generate smoke, meeting the needs of smokers, and unlike traditional rolled cigarettes, the cut tobacco of heated non-combustible tobacco products is in the heating state rather than burning, so it is not the high-temperature combustion decomposition of traditional cigarettes. The harmful components produced by the e-cigarette are reduced, which can reduce the harmful components of mainstream smoke, and at the same time, it can also overcome the drawback that e-cigarettes do not have the taste of real cigarettes. As a result, heated, non-combustible tobacco products are becoming increasingly popular with consumers.
現在、加熱式非燃焼タバコ製品は主な成分がニコチンであり、生物学的毒性が高く、刺激性が強く、スロートヒットが明らかである。したがって、加熱式非燃焼タバコ製品の生物学的安全性および刺激性をどのように改善するかは、当技術分野で解決されるべき緊急の問題となっている。 Currently, heated non-combustible tobacco products have nicotine as the main ingredient, have high biological toxicity, strong irritation, and obvious throat hit. Therefore, how to improve the biological safety and irritation properties of heated, non-combustible tobacco products has become an urgent problem to be solved in the art.
本発明は、加熱式非燃焼電子送達製品におけるアナバシンの使用を提供することを目的とする。本発明によって提供される加熱式非燃焼電子送達製品は、既存の加熱式非燃焼電子送達製品と同じ体験を有し、刺激性が少なく、安全性が高い。 The present invention seeks to provide the use of anabasine in heated, non-combustible electron delivery products. The heated non-combustion electron delivery product provided by the present invention has the same experience as the existing heated non-combustion electron delivery product, is less irritating and highly safe.
上記発明の目的を達成するために、本発明は以下の技術的解決手段を提供する。 In order to achieve the above object of the invention, the present invention provides the following technical solutions.
本発明は、加熱式非燃焼電子送達製品におけるアナバシンの使用を提供する。 The present invention provides the use of anabasine in heated, non-combustible electron delivery products.
好ましくは、さまざまなプロセスに応じて、アナバシンと発煙剤、充填物、接着剤、植物繊維、水、エッセンスを使用して加熱式非燃焼電子送達製品用の固体フレークを製造する。 Preferably, anabasine and smoke agents, fillers, adhesives, plant fibers, water, and essences are used to produce solid flakes for heated, non-combustible electron delivery products according to various processes.
本発明は更に固体フレークを提供し、前記固体フレークは、アナバシン0.5~5%、発煙剤5~20%、充填物40~60%、接着剤3~5%、植物繊維1~3%、エッセンス0.1~2%と水のバランスを含む原材料から製造される。 The present invention further provides a solid flake, the solid flake comprising 0.5-5% anabasine, 5-20% smoke agent, 40-60% filler, 3-5% adhesive, 1-3% vegetable fiber. , manufactured from raw materials containing 0.1-2% essence and the balance of water.
好ましくは、前記アナバシンは遊離形で使用される。 Preferably, said anabasine is used in free form.
好ましくは、前記アナバシンは、(-)-S-アナバシン、(-)-R-アナバシン、または(±)-アナバシンを含む。 Preferably, the anabasine comprises (-)-S-anabasine, (-)-R-anabasine, or (±)-anabasine.
好ましくは、前記発煙剤は、グリセロール及び/又はプロピレングリコールである。 Preferably, the fuming agent is glycerol and/or propylene glycol.
好ましくは、前記充填物は草本植物である。 Preferably, the filling is a herbaceous plant.
好ましくは、前記接着剤はポリアニオン性セルロース及び/又はカルボキシメチルセルロースである。 Preferably, the adhesive is polyanionic cellulose and/or carboxymethylcellulose.
本発明はまた、上記技術的解決手段に記載の固体フレークの製造方法を提供し、
アナバシン、発煙剤、充填物、接着剤、植物繊維、エッセンス、水を混合した後、圧延法またはスラリー法で固形フレークを得るステップを含む。
The present invention also provides a method for producing solid flakes according to the above technical solution,
The method includes the step of mixing anabasine, smoke agent, filler, adhesive, vegetable fiber, essence, and water, and then using a rolling method or a slurry method to obtain solid flakes.
本発明はまた、上記技術的解決手段に記載の固体フレークの製造方法を提供し、
アナバシン、発煙剤、エッセンス、水を混合してコーティング液を得るステップ(1)と、
充填物、接着剤、植物繊維を混合してパルプ化し、抄造してベースシートにするステップ(2)と、
前記ステップ(1)で得られたコーティング液を前記ステップ(2)で得られたベースシートにコーティングし、次に製紙法または乾式製紙法により固体フレークを得るステップ(3)と、を含み、
前記ステップ(1)と(2)は実行に順番がない。
The present invention also provides a method for producing solid flakes according to the above technical solution,
a step (1) of mixing anabasine, a smoke agent, essence, and water to obtain a coating liquid;
Step (2) of mixing the filler, adhesive, and vegetable fibers, pulping them, and forming them into a base sheet;
Coating the base sheet obtained in step (2) with the coating liquid obtained in step (1), and then obtaining solid flakes by a papermaking method or a dry papermaking method (3),
The steps (1) and (2) are executed in no particular order.
本発明は、加熱式非燃焼電子送達製品におけるアナバシンの使用を提供する。本発明は、生物学的毒性が低く、刺激性が少ないアナバシンを加熱式非燃焼電子送達製品に適用し、加熱式非燃焼電子送達製品の安全性および味を改善し、刺激性を改善することができる。実施例の結果は、CETI8 V3.0電子タバコ喫煙機が喫煙に使用され、固定喫煙期間が3秒、喫煙頻度が30秒、喫煙容量が55mL、加熱式非燃焼電子送達製品におけるアナバシンの放出量は50~220μg/puff(標準的な喫煙モードでの一口エアロゾルのアルカロイドの質量)に達し、さまざまな消費者のニーズを満たすことを示している。 The present invention provides the use of anabasine in heated, non-combustible electron delivery products. The present invention applies anabasine with low biological toxicity and less irritation to heated non-combustion electron delivery products to improve safety and taste and improve irritation of heated non-combustion electron delivery products. I can do it. The results of the example show that the CETI8 V3.0 electronic cigarette smoking machine was used for smoking, the fixed smoking period was 3 seconds, the smoking frequency was 30 seconds, the smoking volume was 55 mL, and the amount of anabasine released in the heated non-combustion electronic delivery product was reaches 50-220 μg/puff (alkaloid mass of sip aerosol in standard smoking mode), indicating that it meets the needs of various consumers.
本発明は、加熱式非燃焼電子送達製品におけるアナバシンの使用を提供する。 The present invention provides the use of anabasine in heated, non-combustible electron delivery products.
本発明において、前記アナバシンは好ましくは、発煙剤、充填物、接着剤、植物繊維、水、エッセンスを使用して、異なるプロセスに応じて、加熱式非燃焼電子送達製品用の固体フレークを製造することである。 In the present invention, said anabasine is preferably manufactured into solid flakes for heated non-combustion electronic delivery products according to different processes using fuming agents, fillers, adhesives, plant fibers, water, essences. That's true.
本発明において、前記固体フレークは、好ましくは、質量パーセントで、アナバシンの0.5~5%、発煙剤5~20%、充填物40~60%、接着剤3~5%、植物繊維1~3%、エッセンス0.1~2%と水のバランスという原料から製造される。 In the present invention, the solid flakes preferably include, in percent by weight, 0.5-5% of anabasine, 5-20% of smoke agent, 40-60% of filler, 3-5% of adhesive, 1-5% of vegetable fibers. 3%, essence 0.1-2% and water balance.
本発明は更に固体フレークを提供し、質量パーセントで、アナバシン0.5~5%、発煙剤5~20%、充填物40~60%、接着剤3~5%、植物繊維1~3%、エッセンス0.1~2%と水のバランスという原料から製造される。 The present invention further provides solid flakes, in weight percent, 0.5-5% anabasine, 5-20% smoke agent, 40-60% filler, 3-5% adhesive, 1-3% vegetable fiber, It is manufactured from the raw materials of 0.1-2% essence and a balance of water.
質量パーセントで、本発明に記載の固体フレークを製造するための原料は、アナバシンの0.5~5%、好ましくは1~5%、より好ましくは1~3%、さらに好ましくは1~2%を含む。本発明において、前記アナバシンは好ましくは、遊離形で使用され、前記アナバシンは好ましくは、(+)-R-アナバシン、(-)-R-アナバシン、または(±)-アナバシンを含む。本発明は、前記アナバシンの供給源に特別な制限はなく、当業者に周知の市販の製品を使用すればよい。本発明において、前記アナバシンの生物毒性は低く、分子量は小さく、揮発しやすく、発煙剤の作用下で、アナバシンを人体に効果的に送達することで、ニコチンと同じ体験効果をもたらすことができる。 In weight percent, the raw material for producing the solid flakes according to the invention comprises 0.5 to 5%, preferably 1 to 5%, more preferably 1 to 3%, even more preferably 1 to 2% of anabasine. including. In the present invention, said anabasine is preferably used in free form, said anabasine preferably comprising (+)-R-anabasine, (-)-R-anabasine, or (±)-anabasine. In the present invention, the source of anabasine is not particularly limited, and commercially available products well known to those skilled in the art may be used. In the present invention, the biotoxicity of the anabasine is low, the molecular weight is small, and it is easily volatile, so that under the action of fuming agents, anabasine can be effectively delivered to the human body, resulting in the same experience effect as nicotine.
質量パーセントで、本発明に記載の固体フレークを製造するための原料はさらに、発煙剤の5~20%、好ましくは5~15%、より好ましくは10~15%を含む。本発明において、前記発煙剤は好ましくは、グリセロール及び/又はプロピレングリコールであり、前記発煙剤がグリセリンとプロピレングリコールの場合、前記グリセリンとプロピレングリコールの質量比は好ましくは3:1または2:1である。本発明は、前記発煙剤の供給源に特別な制限はなく、当業者に周知の市販の製品を使用すればよい。本発明において、前記発煙剤はアナバシンの放出を促進し、人体へのアナバシンの効果的な送達を実現することができる。 In percent by weight, the raw material for producing the solid flakes according to the invention further comprises 5 to 20%, preferably 5 to 15%, more preferably 10 to 15% of fuming agent. In the present invention, the smoke generating agent is preferably glycerol and/or propylene glycol, and when the smoke generating agent is glycerin and propylene glycol, the mass ratio of the glycerin and propylene glycol is preferably 3:1 or 2:1. be. In the present invention, the source of the smoke generating agent is not particularly limited, and commercially available products well known to those skilled in the art may be used. In the present invention, the fuming agent can promote the release of anabasine and achieve effective delivery of anabasine to the human body.
本発明に記載の固体フレークを製造するための原料は、質量パーセントで、充填物の40~60%、好ましくは50~60%を含む。本発明において、前記充填物は好ましくは、草本植物であり、より好ましくは緑茶、ミントおよびコーヒーのうちの1つまたは複数であり、充填物が緑茶とミントの場合、前記緑茶とミントの質量比は好ましくは5:1であり、充填物が緑茶とコーヒーの場合、前記緑茶とコーヒーの質量比は好ましくは5:1である。本発明は、前記充填物の供給源に特別な制限はなく、当業者に周知の市販の製品を使用すればよい。本発明において、前記充填物は、固体フレークにおいて、充填の役割を果たし、固体フレークのコストを削減できる。 The raw material for producing the solid flakes according to the invention comprises, in weight percent, 40-60%, preferably 50-60%, of filler. In the present invention, the filling is preferably a herbaceous plant, more preferably one or more of green tea, mint and coffee, and when the filling is green tea and mint, the mass ratio of the green tea and mint is is preferably 5:1, and when the filling is green tea and coffee, the mass ratio of said green tea and coffee is preferably 5:1. The present invention is not particularly limited to the source of the filler, and commercially available products well known to those skilled in the art may be used. In the present invention, the filler plays a filling role in the solid flakes, and can reduce the cost of the solid flakes.
本発明に記載の固体フレークを製造するための原料は、質量パーセントで、接着剤の3~5%、好ましくは4~5%をさらに含む。本発明において、前記接着剤は好ましくは、ポリアニオン性セルロース及び/又はカルボキシメチルセルロースであり、より好ましくはポリアニオン性セルロース及びカルボキシメチルセルロースであり、前記接着剤はポリアニオン性セルロース及びカルボキシメチルセルロースである場合、前記ポリアニオン性セルロースとカルボキシメチルセルロースの体積比は、好ましくは1:1である。本発明は、前記接着剤の供給源に特別な制限はなく、当業者に周知の市販の製品を使用すればよい。本発明において、前記接着剤は、各原料を結合するための結合剤として機能する。 The raw material for producing the solid flakes according to the invention further comprises, in weight percent, 3-5%, preferably 4-5% of adhesive. In the present invention, the adhesive is preferably polyanionic cellulose and/or carboxymethylcellulose, more preferably polyanionic cellulose and carboxymethylcellulose, and when the adhesive is polyanionic cellulose and carboxymethylcellulose, the polyanionic The volume ratio of sterile cellulose and carboxymethylcellulose is preferably 1:1. The present invention is not particularly limited to the source of the adhesive, and commercially available products well known to those skilled in the art may be used. In the present invention, the adhesive functions as a binding agent for binding each raw material.
本発明に記載の固体フレークを製造するための原料は、質量パーセントで、植物繊維の1~3%、好ましくは2~3%をさらに含む。本発明において、前記植物繊維は、好ましくは木材パルプ繊維である。本発明は、前記木材パルプ繊維のサイズに特別な制限はなく、常識に従って選択すればよい。本発明は、前記植物繊維の供給源に特別な制限はなく、当業者に周知の市販の製品を使用すればよい。本発明において、前記植物繊維は、固体フレークの強度を高めるのに役立つ。 The raw material for producing the solid flakes according to the invention further comprises 1 to 3%, preferably 2 to 3%, of vegetable fibers in weight percent. In the present invention, the vegetable fiber is preferably wood pulp fiber. In the present invention, the size of the wood pulp fibers is not particularly limited, and may be selected according to common sense. In the present invention, there is no particular restriction on the source of the plant fibers, and commercially available products well known to those skilled in the art may be used. In the present invention, the vegetable fibers serve to increase the strength of the solid flakes.
本発明に記載の固体フレークを製造するための原料は、質量パーセントで、0.1~2%のエッセンス、好ましくは1~2%のエッセンスをさらに含む。本発明において、前記エッセンスは、好ましくは植物抽出物または合成エッセンスであり、より好ましくはストロベリーエッセンス、ミントエッセンス、アップルエッセンスおよび清涼剤のうちの少なくとも1つ、さらに好ましくはストロベリーエッセンス、ミントエッセンス、アップルエッセンスおよび清涼剤のうちの2つであり、前記エッセンスがストロベリーエッセンスとミントエッセンスの場合、前記ストロベリーエッセンスとミントエッセンスの質量比は好ましくは、1:1であり、前記エッセンスがストロベリーエッセンスとアップルエッセンスの場合、前記ストロベリーエッセンスとアップルエッセンスの質量比は好ましくは、2:1であり、前記エッセンスがストロベリーエッセンスと清涼剤の場合、前記ストロベリーエッセンスと清涼剤の質量比は好ましくは1.5:1である。本発明は、前記エッセンスの供給源に特別な制限はなく、当業者に周知の市販の製品を使用すればよい。本発明において、前記エッセンスは、固体フレークに必要な香りを提供するために使用される。 The raw material for producing the solid flakes according to the invention further comprises, in weight percent, 0.1-2% essence, preferably 1-2% essence. In the present invention, the essence is preferably a plant extract or a synthetic essence, more preferably at least one of strawberry essence, mint essence, apple essence, and a refreshing agent, and even more preferably strawberry essence, mint essence, apple essence. two of an essence and a refreshing agent, and the essences are strawberry essence and mint essence, the mass ratio of the strawberry essence and mint essence is preferably 1:1, and the essences are strawberry essence and apple essence. In this case, the mass ratio of the strawberry essence and apple essence is preferably 2:1, and when the essence is strawberry essence and a refreshing agent, the mass ratio of the strawberry essence and the refreshing agent is preferably 1.5:1. It is. In the present invention, there is no particular restriction on the source of the essence, and commercially available products well known to those skilled in the art may be used. In the present invention, said essence is used to provide the necessary aroma to the solid flakes.
本発明に記載の固体フレークを製造するための原料は、質量パーセントで、また水のバランスを含む。本発明は、前記水の供給源に特別な制限はなく、当業者に周知の市販の製品を使用すればよい。本発明において、前記水は溶剤であり、原料を溶解する役割を果たす。 The raw materials for producing the solid flakes according to the invention include, in weight percent, also the balance of water. In the present invention, there is no particular restriction on the water supply source, and commercially available products well known to those skilled in the art may be used. In the present invention, the water is a solvent and serves to dissolve raw materials.
本発明では、アナバシンを他の原料と組み合わせてタバコ添加物の代わりに使用し、加熱式非燃焼装置を用いてアナバシンを人体に効果的に送達することにより、ニコチンと同様の体験効果をもたらすことができる。 The present invention uses anabasine in combination with other ingredients to replace tobacco additives, and uses a heated non-combustion device to effectively deliver anabasine to the human body, resulting in an experiential effect similar to that of nicotine. I can do it.
従来の加熱式非燃焼固形タバコ製品と比較して、本発明によって提供される固体フレークは、ニコチンの使用を低減または置換し、ニコチンへの依存を低減することができる。 Compared to conventional heat-not-burn solid tobacco products, the solid flakes provided by the present invention can reduce or replace the use of nicotine and reduce dependence on nicotine.
本発明で使用されるアナバシンは、明らかなスロートヒットがなく、刺激性が小さく、固体フレークを製造して、得られた固体フレークは加熱式非燃焼装置で加熱されてアナバシンを含むエアロゾルを形成してアナバシジンの送達を完了し、加熱式非燃焼装置での使用に適しており、安全性の高い電子伝達製品である。 The anabasine used in the present invention has no obvious throat hit, is less irritating, and produces solid flakes that are heated in a heated non-combustion device to form an aerosol containing anabasine. It is a highly safe electron transfer product that is suitable for use in heated non-combustion devices and is suitable for use in heated non-combustion devices.
本発明によって提供されるアナバシンは、高含有量(質量パーセント≧98%)の特徴を有し、天然ニコチンには、タバコに特有の4つのニトロソアミン成分(ニトロソアナタビンNAT、ニトロソノルニコジンNNN、ニトロソアナバシンNABおよびメチルニトロサミノピリジルブタノンNNK)が含まず、生物学的安全性が高い。 The anabasine provided by the present invention is characterized by a high content (mass percentage ≧98%), and the natural nicotine contains four nitrosamine components specific to tobacco: nitrosoanatabine NAT, nitrosonornicodine NNN, It does not contain nitrosoanabasin (NAB and methylnitrosaminopyridylbutanone (NNK)) and has high biological safety.
ラットにおけるアナバシンとニコチンの急性吸入毒性評価の結果は、アナバシンの吸入半数致死用量(LC50)値が125mg/kgであり、ニコチン吸入半数致死用量(LC50)値が37.8mg/kgであることを示し、ニコチンと比較して、アナバシンは生物学的安全性が高く、タバコ製品の代替品として加熱式非燃焼電子送達製品において使用できる。 The results of the acute inhalation toxicity evaluation of anabasine and nicotine in rats showed that the inhalation half-lethal dose (LC50) value of anabasine was 125 mg/kg and the inhalation half-lethal dose (LC50) value of nicotine was 37.8 mg/kg. Compared to nicotine, anabasine is more biologically safe and can be used in heated, non-combustible electronic delivery products as an alternative to tobacco products.
本発明はまた、上記技術的解決手段に記載の固体フレークの製造方法を提供し、
アナバシン、発煙剤、充填物、接着剤、植物繊維、エッセンス、水を混合した後、圧延法またはスラリー法で固形フレークを得るステップを含む。
The present invention also provides a method for producing solid flakes according to the above technical solution,
The method includes the step of mixing anabasine, smoke agent, filler, adhesive, vegetable fiber, essence, and water, and then using a rolling method or a slurry method to obtain solid flakes.
本発明において、アナバシン、発煙剤、充填物、接着剤、植物繊維、エッセンス、水を混合した後、圧延法またはスラリー法で固形フレークを得る。 In the present invention, solid flakes are obtained by a rolling method or a slurry method after mixing anabasine, a smoke agent, a filler, an adhesive, a vegetable fiber, an essence, and water.
本発明において、前記充填物は使用前に好ましくは、粉砕する。本発明は、前記粉砕操作に特別な制限はなく、使用要件を満たすように充填物を粉砕すればよい。 In the present invention, the filler is preferably ground before use. In the present invention, there is no particular restriction on the pulverization operation, and the filler may be pulverized to meet usage requirements.
本発明は、前記アナバシン、発煙剤、充填物、接着剤、植物繊維、エッセンス、水を混合する操作に特別な制限はなく、当業者に周知の混合材料を調製するための技術的解決手段を使用すればよい。 The present invention does not have any special limitations on the operation of mixing said anabasine, smoke agent, filler, adhesive, vegetable fiber, essence, water, and uses technical solutions for preparing mixed materials well known to those skilled in the art. Just use it.
本発明は、前記圧延法およびスラリー法の具体的な操作に特別な制限はなく、当業者に周知の操作を使用すればよい。 In the present invention, there is no particular restriction on the specific operations of the rolling method and the slurry method, and operations well known to those skilled in the art may be used.
本発明はまた、上記技術的解決手段に記載の固体フレークの製造方法を提供し、
アナバシン、発煙剤、エッセンス、水を混合してコーティング液を得るステップ(1)と、
充填物、接着剤、植物繊維を混合してパルプ化し、抄造してベースシートにするステップ(2)と、
前記ステップ(1)で得られたコーティング液を前記ステップ(2)で得られたベースシートにコーティングし、次に製紙法または乾式製紙法により固体フレークを得るステップ(3)と、を含み、
前記ステップ(1)と(2)は実行に順番がない。
The present invention also provides a method for producing solid flakes according to the above technical solution,
a step (1) of mixing anabasine, a smoke agent, essence, and water to obtain a coating liquid;
Step (2) of mixing the filler, adhesive, and vegetable fibers, pulping them, and forming them into a base sheet;
Coating the base sheet obtained in step (2) with the coating liquid obtained in step (1), and then obtaining solid flakes by a papermaking method or a dry papermaking method (3),
The steps (1) and (2) are executed in no particular order.
本発明では、アナバシン、発煙剤、エッセンス、水を混合してコーティング液を得る。 In the present invention, a coating liquid is obtained by mixing anabasine, a fuming agent, essence, and water.
本発明は、アナバシン、発煙剤、エッセンスおよび水を混合する操作に特別な制限はなく、当業者に周知の混合材料を調製するための技術的解決手段を使用すればよい。 The present invention does not impose any particular limitations on the operation of mixing anabasine, smoke agent, essence and water, and any technical solutions for preparing mixed materials well known to those skilled in the art may be used.
本発明では、充填物、接着剤、および植物繊維を混合してパルプ化し、次にベースシートにする。 In the present invention, the filler, adhesive, and vegetable fibers are mixed and pulped into a base sheet.
本発明において、前記充填物は使用前に好ましくは、粉砕する。本発明は、前記粉砕操作に特別な制限はなく、使用要件を満たすように充填物を粉砕すればよい。 In the present invention, the filler is preferably ground before use. In the present invention, there is no particular restriction on the pulverization operation, and the filler may be pulverized to meet usage requirements.
本発明における充填物、接着剤および植物繊維を混合する操作は、特に限定されるものではなく、当業者に周知の混合材料を調製するための技術的解決手段を使用すればよい。本発明は、前記パルプ化および製紙の操作に特別な制限はなく、当業者に周知の操作を使用すればよい。 The operation of mixing the filler, adhesive and vegetable fibers in the present invention is not particularly limited, and any technical solutions for preparing mixed materials well known to those skilled in the art may be used. The present invention is not particularly limited to the pulping and papermaking operations, and operations well known to those skilled in the art may be used.
コーティング液とベースシートが得られた後、本発明は、ベースシート上に前記コーティング液をコーティングし、次に製紙法または乾式製紙法を使用して、固体フレークを得る。 After the coating liquid and base sheet are obtained, the present invention coats the coating liquid on the base sheet, and then uses a papermaking method or a dry papermaking method to obtain solid flakes.
本発明は、前記コーティング操作に特別な制限はなく、当業者に周知のコーティング操作を使用すればよい。本発明は、前記製紙法および乾式製紙法の具体的な操作に特別な制限はなく、当業者に周知の操作を使用すればよい。 In the present invention, there is no particular restriction on the coating operation, and any coating operation well known to those skilled in the art may be used. In the present invention, there are no particular limitations on the specific operations of the papermaking method and dry papermaking method, and operations well known to those skilled in the art may be used.
本発明によって提供される製造方法は、単純なプロセスを有し、工業生産に適している。 The manufacturing method provided by the present invention has a simple process and is suitable for industrial production.
以下に本発明における実施例を参照しながら、本発明のにおける技術的解決手段を明確で、完全に説明する。明らかに、記載された実施例は、本発明のすべてではないが一部の実施例にすぎない。本発明の実施例に基づいて、創造的な作業なしに当業者によって得られる他のすべての実施例は、本発明の保護範囲に含まれる。 The technical solution of the present invention will be explained clearly and completely below with reference to the embodiments of the present invention. Obviously, the described embodiments are only some, but not all, embodiments of the invention. All other embodiments obtained by those skilled in the art based on the embodiments of the present invention without creative work fall within the protection scope of the present invention.
実施例1
固体フレークは、質量パーセントで1%(±)-アナバシン、15%発煙剤、60%充填物、5%接着剤、3%植物繊維、2%エッセンス、および残りの水という原料から製造された。
Example 1
The solid flakes were made from the following ingredients in weight percent: 1% (±)-anabasine, 15% smoke agent, 60% filler, 5% adhesive, 3% vegetable fiber, 2% essence, and the balance water.
ここで、発煙剤はグリセロールとプロピレングリコール(質量比は2:1)、充填物は緑茶、接着剤はカルボキシメチルセルロース、植物繊維は木材パルプ繊維、エッセンスはストロベリーエッセンスとミントエッセンス(比率は1:1)であり、
前記固体フレークの製造方法は、
(±)-アナバシン、発煙剤、粉砕後の充填物、接着剤、植物繊維、エッセンス及び水を混合した後、圧延および乾燥した後、固体フレークを得るステップを含む。
Here, the smoke agent is glycerol and propylene glycol (mass ratio is 2:1), the filler is green tea, the adhesive is carboxymethyl cellulose, the vegetable fiber is wood pulp fiber, and the essence is strawberry essence and mint essence (ratio is 1:1). ) and
The method for producing the solid flakes includes:
(±)-Anabasine, smoke agent, crushed filler, adhesive, vegetable fiber, essence and water are mixed and then rolled and dried to obtain solid flakes.
CETI8 V3.0電子タバコ喫煙機を使用して、実施例1で製造した固体フレークを喫煙し、電子タバコ喫煙では、CORESTAが推奨する電子タバコ喫煙モード(固定喫煙持続時間は3秒、喫煙頻度は30秒、喫煙量は55mL、方形波喫煙曲線)を使用し、ケンブリッジフィルターを使用してエアロゾル中の総粒子状物質を捕捉し、GC-FID分析により、加熱式非燃焼装置でのアナバシンの放出量が100μg/puffに達したことが示された。 A CETI8 V3.0 electronic cigarette smoking machine was used to smoke the solid flakes produced in Example 1, and for electronic cigarette smoking, the electronic cigarette smoking mode recommended by CORESTA (fixed smoking duration was 3 seconds, smoking frequency was The release of anabasine in a heated non-combustion device was determined by GC-FID analysis using a Cambridge filter to capture the total particulate matter in the aerosol. It was shown that the amount reached 100 μg/puff.
実施例2
固体フレークは、次の質量パーセントで3%(±)-アナバシン、10%発煙剤、60%充填物、5%接着剤、3%植物繊維、2%エッセンス、および残りの水という原料から製造された。
Example 2
The solid flakes were made from the following raw materials: 3% (±)-anabasine, 10% smoke agent, 60% filler, 5% adhesive, 3% vegetable fiber, 2% essence, and the balance water in the following weight percentages: Ta.
ここで、発煙剤はグリセロールとプロピレングリコール(質量比は3:1)、充填物は緑茶とミント(質量比は5:1)、接着剤はポリアニオン性セルロース及びカルボキシメチルセルロース(体積比は1:1)、植物繊維は、木材パルプ繊維、エッセンスはストロベリーエッセンスとアップルエッセンス(質量比は2:1)であり、
前記固体フレークの製造方法は、
(±)-アナバシン、発煙剤、粉砕後の充填物、接着剤、植物繊維、エッセンス及び水を混合した後にスラリーを形成し、循環する金属ベルト上に均一に広げ、乾燥させて剥がし、固体フレークを作成したことである。
Here, the smoke agent is glycerol and propylene glycol (mass ratio 3:1), the filler is green tea and mint (mass ratio 5:1), and the adhesive is polyanionic cellulose and carboxymethyl cellulose (volume ratio 1:1). ), the plant fibers are wood pulp fibers, the essences are strawberry essence and apple essence (mass ratio 2:1),
The method for producing the solid flakes includes:
(±) - Form a slurry after mixing anabasine, smoke agent, filler after grinding, adhesive, vegetable fiber, essence and water, spread it evenly on a circulating metal belt, dry and peel off, solid flakes was created.
CETI8 V3.0電子タバコ喫煙機を使用して、実施例2で製造した固体フレークを喫煙し、電子タバコ喫煙では、CORESTAが推奨する電子タバコ喫煙モード(固定喫煙持続時間は3秒、喫煙頻度は30秒、喫煙量は55mL、方形波喫煙曲線)を使用し、ケンブリッジフィルターを使用してエアロゾル中の総粒子状物質を捕捉し、GC-FID分析により、加熱式非燃焼装置でのアナバシンの放出量が180μg/puffに達したことが示された。 A CETI8 V3.0 electronic cigarette smoking machine was used to smoke the solid flakes produced in Example 2, and for electronic cigarette smoking, the electronic cigarette smoking mode recommended by CORESTA (fixed smoking duration was 3 seconds, smoking frequency was The release of anabasine in a heated non-combustion device was determined by GC-FID analysis using a Cambridge filter to capture the total particulate matter in the aerosol. It was shown that the amount reached 180 μg/puff.
実施例3
固体フレークは、質量パーセントで5%(±)-アナバシン、10%発煙剤、60%充填物、5%接着剤、3%植物繊維、2%エッセンス、および残りの水という原料から製造された。
Example 3
The solid flakes were made from the following ingredients in weight percent: 5% (±)-anabasine, 10% smoke agent, 60% filler, 5% adhesive, 3% vegetable fiber, 2% essence, and the balance water.
ここで、発煙剤は、グリセロール、充填物は緑茶とコーヒー(質量比は5:1)、接着剤はカルボキシメチルセルロース、植物繊維は、木材パルプ繊維、エッセンスはストロベリーエッセンスと清涼剤(質量比は1.5:1)であり、
前記固体フレークの製造方法は、
(±)-アナバシン、発煙剤、エッセンス、水を混合してコーティング液を得るステップ(1)と、
粉砕後の充填物、接着剤、植物繊維を混合してパルプ化し、抄造してベースシートにするステップ(2)と、
前記ステップ(1)で得られたコーティング液を前記ステップ(2)で得られたベースシートにコーティングし、次に製紙法または乾式製紙法により固体フレークを得るステップ(3)と、を含む。
Here, the smoke agent is glycerol, the filler is green tea and coffee (mass ratio is 5:1), the adhesive is carboxymethyl cellulose, the vegetable fiber is wood pulp fiber, and the essence is strawberry essence and refreshing agent (mass ratio is 1). .5:1),
The method for producing the solid flakes includes:
(±)-A step (1) of mixing anabasine, a smoke agent, an essence, and water to obtain a coating liquid;
A step (2) of mixing the crushed filler, adhesive, and vegetable fibers into a pulp, and making a paper into a base sheet;
The method includes a step (3) of coating the base sheet obtained in step (2) with the coating liquid obtained in step (1) above, and then obtaining solid flakes by a papermaking method or a dry papermaking method.
CETI8 V3.0電子タバコ喫煙機を使用して、実施例3で製造した固体フレークを喫煙し、電子タバコ喫煙では、CORESTAが推奨する電子タバコ喫煙モード(固定喫煙持続時間は3秒、喫煙頻度は30秒、喫煙量は55mL、方形波喫煙曲線)を使用し、ケンブリッジフィルターを使用してエアロゾル中の総粒子状物質を捕捉し、GC-FID分析により、加熱式非燃焼装置でのアナバシンの放出量が205μg/puffに達したことが示された。 A CETI8 V3.0 electronic cigarette smoking machine was used to smoke the solid flakes produced in Example 3, and for electronic cigarette smoking, the electronic cigarette smoking mode recommended by CORESTA (fixed smoking duration was 3 seconds, smoking frequency was The release of anabasine in a heated non-combustion device was determined by GC-FID analysis using a Cambridge filter to capture the total particulate matter in the aerosol. It was shown that the amount reached 205 μg/puff.
実施例4
固体フレークは、質量パーセントで1%(-)-S-アナバシン、15%発煙剤、60%充填物、5%接着剤、3%植物繊維、2%エッセンス、および残りの水という原料から製造された。
Example 4
The solid flakes were produced from the following raw materials in weight percent: 1% (-)-S-anabasine, 15% smoke agent, 60% filler, 5% adhesive, 3% vegetable fiber, 2% essence, and the balance water. Ta.
ここで、発煙剤は、グリセロールとプロピレングリコール(質量比は2:1)、充填物は緑茶、接着剤はカルボキシメチルセルロース、植物繊維は、木材パルプ繊維、エッセンスはストロベリーエッセンスとミントエッセンス(質量比は1:1)であり、
前記固体フレークの製造方法は、
(-)-S-アナバシン、発煙剤、粉砕後の充填物、接着剤、植物繊維、エッセンス、水を混合した後、圧延して乾燥させて固形フレークを得たステップを含む。
Here, the smoke agent is glycerol and propylene glycol (mass ratio is 2:1), the filler is green tea, the adhesive is carboxymethyl cellulose, the vegetable fiber is wood pulp fiber, and the essence is strawberry essence and mint essence (mass ratio is 1:1),
The method for producing the solid flakes includes:
The method includes a step of mixing (-)-S-anabasine, a smoke agent, a crushed filler, an adhesive, a vegetable fiber, an essence, and water, and then rolling and drying the mixture to obtain solid flakes.
CETI8 V3.0電子タバコ喫煙機を使用して、実施例1で製造した固体フレークを喫煙し、電子タバコ喫煙では、CORESTAが推奨する電子タバコ喫煙モード(固定喫煙持続時間は3秒、喫煙頻度は30秒、喫煙量は55mL、方形波喫煙曲線)を使用し、ケンブリッジフィルターを使用してエアロゾル中の総粒子状物質を捕捉し、GC-FID分析により、加熱式非燃焼装置でのアナバシンの放出量が98μg/puffに達したことが示された。 A CETI8 V3.0 electronic cigarette smoking machine was used to smoke the solid flakes produced in Example 1, and for electronic cigarette smoking, the electronic cigarette smoking mode recommended by CORESTA (fixed smoking duration was 3 seconds, smoking frequency was The release of anabasine in a heated non-combustion device was determined by GC-FID analysis using a Cambridge filter to capture the total particulate matter in the aerosol. It was shown that the amount reached 98 μg/puff.
実施例5
固体フレークは、質量パーセントで1%(-)-R-アナバシン、15%発煙剤、60%充填物、5%接着剤、3%植物繊維、2%エッセンス、および残りの水という原料から製造された。
Example 5
The solid flakes were produced from the following raw materials in weight percent: 1% (-)-R-anabasine, 15% smoke agent, 60% filler, 5% adhesive, 3% vegetable fiber, 2% essence, and the balance water. Ta.
ここで、発煙剤は、グリセロールとプロピレングリコール(質量比は2:1)、充填物は緑茶、接着剤はカルボキシメチルセルロース、植物繊維は、木材パルプ繊維、エッセンスはストロベリーエッセンスとミントエッセンス(質量比は1:1)であり、
前記固体フレークの製造方法は、
(-)-R-アナバシン、発煙剤、粉砕後の充填物、接着剤、植物繊維、エッセンス、水を混合した後、圧延して乾燥させて固形フレークを得たステップを含む。
Here, the smoke agent is glycerol and propylene glycol (mass ratio is 2:1), the filler is green tea, the adhesive is carboxymethyl cellulose, the vegetable fiber is wood pulp fiber, and the essence is strawberry essence and mint essence (mass ratio is 1:1),
The method for producing the solid flakes includes:
The method includes a step of mixing (-)-R-anabasine, a smoke agent, a crushed filler, an adhesive, a vegetable fiber, an essence, and water, and then rolling and drying the mixture to obtain solid flakes.
CETI8 V3.0電子タバコ喫煙機を使用して、実施例1で製造した固体フレークを喫煙し、電子タバコ喫煙では、CORESTAが推奨する電子タバコ喫煙モード(固定喫煙持続時間は3秒、喫煙頻度は30秒、喫煙量は55mL、方形波喫煙曲線)を使用し、ケンブリッジフィルターを使用してエアロゾル中の総粒子状物質を捕捉し、GC-FID分析により、加熱式非燃焼装置でのアナバシンの放出量が102μg/puffに達したことが示された。 A CETI8 V3.0 electronic cigarette smoking machine was used to smoke the solid flakes produced in Example 1, and for electronic cigarette smoking, the electronic cigarette smoking mode recommended by CORESTA (fixed smoking duration was 3 seconds, smoking frequency was The release of anabasine in a heated non-combustion device was determined by GC-FID analysis using a Cambridge filter to capture the total particulate matter in the aerosol. It was shown that the amount reached 102 μg/puff.
性能試験:
SDラットの急性吸入毒性試験によってアナバシン(ANA)のエアロゾル吸入半数致死用量(LC50)および明らかに損傷を与えない効果用量(NOAEL)を計算し、ニコチン(NIC)の急性吸入毒性結果と比較した。急性吸入毒性試験の結果に基づいて、ANAの亜急性毒性試験研究をさらに実施し、ANAが気道から動物の体内に入った後の呼吸器組織および全身への損傷および危害の程度を評価し、また、電子送達製品へのANAの使用に関する安全性評価を提供した。
performance test:
The aerosol inhalation half-lethal dose (LC50) and non-injurious effective dose (NOAEL) of anabasine (ANA) were calculated by acute inhalation toxicity studies in SD rats and compared with the acute inhalation toxicity results of nicotine (NIC). Based on the results of the acute inhalation toxicity test, further conduct a subacute toxicity test study of ANA to evaluate the degree of damage and harm to respiratory tissues and the whole body after ANA enters the animal body through the respiratory tract; It also provided a safety evaluation for the use of ANA in electronic delivery products.
1.材料及び方法
1.1供試体
ANA、純度≧98%、浅黄色の油性液体、NIC、純度≧95%、黄色の油性液体、プロピレングリコール(PG)、野菜グリセリン(VG)
1.2試験品の調製と試験のグループ化
ブランク対照群(Sham Control)吸入空気、陰性対照群(Vehicle Control)試験品は、質量比PG:VG=50:50に従って調製され、1%ANAは、質量比ANA:PG:VG=1:49.5:49.5に従って調製され、5%ANAは質量比ANA:PG:VG=5:47.5:47.5に従って調製され、10%ANAは質量比ANA:PG:VG=10:45:45に従って調製され、15%ANAは質量比ANA:PG:VG=15:42.5:42.5に従って調製され、20%ANAは質量比ANA:PG:VG=20:40:40に従って調製され、1%NICは質量比NIC:PG:VG=1:49.5:49.5に従って調製され、3%NICは質量比NIC:PG:VG=3:48.5:48.5に従って調製され、5%NICは質量比NIC:PG:VG=5:47.5:47.5に従って調製され、10%NICは質量比NIC:PG:VG=10:45:45に従って調製された。
1.3試験動物と飼育環境
SPFグレードSDラットを使用して、半分はオス、半分はメスである。動物を導入した後、適応チェックを行い、適応期間中はケージあたり2匹の動物がおり、適応時間は12~13日であり、導入当日に健康診断を行い、且つ体重を秤量した。飼料は滅菌された正規価格の栄養粉末、水の飲みを制限せず、動物室の温度は20~25℃、湿度は45%~70%、光周期は自動的に制御され、毎日明暗はそれぞれ12時間であった。
1.4試験機器
HRH-BAG1衝撃液体エアロゾル発生器、HRH-MNE3026小動物単一濃度口鼻曝露システム、北京慧榮和科技有限公司、3321医薬品エアロゾル粒径分析システム、TSI Corporation、米国。
1.5急性毒性テスト
OECD化学物質試験ガイドラインの急性吸入毒性試験(NO.403、2009)の要件によれば、雄5匹と雄5匹のラットがあり、動物をHRH-MNE3026小動物単一濃度口鼻暴露システムホルダーに入れたリテーナーを毒ガスキャビネットに取り付け、毒ガスキャビネットを密閉し、ブランク対照群(Sham Control)、陰性対照群(Vehicle Control)、4つのANA試験品エアロゾル(5mg/L)、4つのNIC試験品エアロゾル(5mg/L)に曝露し、ラットの暴露時間はすべて、4時間であった。暴露期間中、臨床観察を行い、各群の死亡動物と生存動物の数を数えた。その後、生存ラットを14日間継続的に観察した。それぞれガスANAおよびNIC吸入のLC50およびNOAEL値を計算した。
1.6亜急性毒性試験
ANA急性毒性試験の総合評価に基づき、最大暴露用量としてANA吸入NOAELを使用し、体重に応じて、ランダムにブランク対照群(Sham Control)、陰性対照群(Vehicle Control)、ANA高、中、低用量群の5つのグループに分けられ、各グループに10匹であり、半分はオス、半分はメスである。グループに分ける時にグループ内の動物の体重は、平均体重の±20%を超えなかった。動物をそれぞれHRH-MNE3026小動物単一濃度口鼻暴露システムリテーナー内に入れ、リテーナーを毒ガスキャビネットに取り付け、毒ガスキャビネットを密閉し、1日1回で28日間曝露し続いた。
臨床症状の観察:28日間の経鼻吸入暴露期間中、実験動物の刺激性、罹患率、死亡率を観察し、動物の体重と摂餌量を定期的に測定した。
病理学的検査:実験の最後に、生き残ったすべての動物に対して肉眼的剖検を実施した。呼吸器系および代謝系(肺、肝臓、腎臓など)を含む、解剖中の動物を徹底的かつ注意深く肉眼的観察し、各動物の肉眼的病理学的変化を詳細に記録した。
1.7データ処理と結果分析
各グループの動物の数、症状、死亡、生存率、および肉眼解剖学と組織病理学的検査中のさまざまな病変の頻度をそれぞれカウントし、さまざまなグループおよびさまざまな性別の動物における上記の項目の発生率と、さまざまな時点での体重の平均値および標準偏差を計算した。
1. Materials and methods 1.1 Specimen ANA, purity ≧98%, pale yellow oily liquid, NIC, purity ≧95%, yellow oily liquid, propylene glycol (PG), vegetable glycerin (VG)
1.2 Preparation of test articles and test grouping Blank control group (Sham Control) inhaled air, negative control group (Vehicle Control) test articles were prepared according to the mass ratio PG:VG = 50:50, 1% ANA , 5% ANA was prepared according to the mass ratio ANA:PG:VG=5:47.5:47.5, and 10% ANA was prepared according to the mass ratio ANA:PG:VG=5:47.5:47.5. was prepared according to the mass ratio ANA:PG:VG = 10:45:45, 15% ANA was prepared according to the mass ratio ANA:PG:VG = 15:42.5:42.5, and 20% ANA was prepared according to the mass ratio ANA:PG:VG = 15:42.5:42.5. :PG:VG=20:40:40, 1% NIC was prepared according to mass ratio NIC:PG:VG=1:49.5:49.5, 3% NIC was prepared according to mass ratio NIC:PG:VG = 3:48.5:48.5, 5% NIC was prepared according to the mass ratio NIC:PG:VG = 5:47.5:47.5, 10% NIC was prepared according to the mass ratio NIC:PG:VG =10:45:45.
1.3 Test animals and housing environment SPF grade SD rats were used, half male and half female. After introducing the animals, an adaptation check was performed, there were 2 animals per cage during the adaptation period, the adaptation time was 12-13 days, and a health check was performed and the weight was weighed on the day of introduction. The feed is sterilized nutritional powder at the regular price, drinking water is not restricted, the temperature of the animal room is 20-25℃, the humidity is 45%-70%, the photoperiod is automatically controlled, and the light and dark are adjusted each day. It was 12 hours.
1.4 Test Equipment HRH-BAG1 Impact Liquid Aerosol Generator, HRH-MNE3026 Small Animal Single Concentration Oronasal Exposure System, Beijing Huironghe Technology Co., Ltd., 3321 Pharmaceutical Aerosol Particle Size Analysis System, TSI Corporation, USA.
1.5 Acute Toxicity Test According to the requirements of OECD Chemical Testing Guidelines for Acute Inhalation Toxicity Test (NO.403, 2009), there are 5 male and 5 male rats, and the animals are tested at HRH-MNE3026 small animal single concentration. Attach the retainer in the oronasal exposure system holder to the poison gas cabinet, seal the poison gas cabinet, and inject the blank control group (Sham Control), negative control group (Vehicle Control), 4 ANA test product aerosols (5 mg/L), 4 All rats were exposed to two NIC test article aerosols (5 mg/L) for 4 hours. During the exposure period, clinical observations were made and the number of dead and living animals in each group was counted. Thereafter, surviving rats were continuously observed for 14 days. LC50 and NOAEL values were calculated for gas ANA and NIC inhalation, respectively.
1.6 Subacute toxicity test Based on the comprehensive evaluation of the ANA acute toxicity test, the ANA inhalation NOAEL was used as the maximum exposure dose, and the blank control group (Sham Control) and negative control group (Vehicle Control) were randomly assigned according to body weight. , divided into 5 groups: ANA high, medium, and low dose groups, with 10 animals in each group, half male and half female. When divided into groups, the weight of animals within a group did not exceed ±20% of the mean body weight. Each animal was placed in an HRH-MNE3026 Small Animal Single Concentration Oronasal Exposure System retainer, the retainer was attached to the poison gas cabinet, the poison gas cabinet was sealed, and exposure continued once a day for 28 days.
Observation of clinical symptoms: During the 28-day nasal inhalation exposure period, the irritation, morbidity, and mortality of the experimental animals were observed, and the animals' body weights and food intake were measured regularly.
Pathological examination: At the end of the experiment, gross necropsy was performed on all surviving animals. A thorough and careful macroscopic observation of the animals during dissection was performed, including the respiratory and metabolic systems (lungs, liver, kidneys, etc.), and the gross pathological changes of each animal were recorded in detail.
1.7 Data processing and result analysis The number of animals in each group, symptoms, mortality, survival rate, and frequency of various lesions during gross anatomy and histopathological examination were counted respectively, and the number of animals in each group and the The incidence of the above items in animals of each sex and the mean and standard deviation of body weight at different time points were calculated.
実験結果
2.1NIC急性吸入毒性試験
曝露期間中の毒キャビネットのエアロゾル濃度、NIC吸入用量、および粒径分布を表1に示した。
Experimental Results 2.1 NIC Acute Inhalation Toxicity Test The aerosol concentration, NIC inhalation dose, and particle size distribution of the poison cabinet during the exposure period are shown in Table 1.
注記:表1において、MMADはエアロゾルの質量中央値の空気力学的直径、GSDは幾何標準偏差である。 Note: In Table 1, MMAD is the mass median aerodynamic diameter of the aerosol and GSD is the geometric standard deviation.
臨床症状の観察:NICエアロゾルの吸入用量はそれぞれ、87mg/kg、43.5mg/kg、26.1mg/kg、8.7mg/kgである場合、暴露中に死亡および瀕死の動物の割合はそれぞれ92.7%、67.3%、10.6%、2.5%に達した(図1に示すように、NICエアロゾル吸入用量が87mg/kg、43.5mg/kg、26.1mg/kg、および8.7mg/kgの場合に暴露中のラットの死亡率である)。死んでいない動物は試験終了まで14日間継続して観察され、異常な変化はなかった。 Observation of clinical symptoms: The proportion of dead and moribund animals during exposure was reached 92.7%, 67.3%, 10.6%, and 2.5% (as shown in Figure 1, when the NIC aerosol inhalation dose was 87 mg/kg, 43.5 mg/kg, and 26.1 mg/kg). , and the mortality rate of rats during exposure at 8.7 mg/kg). Non-dead animals were observed continuously for 14 days until the end of the study and there were no abnormal changes.
吸入用量とラット死亡率の統計によると、Graphpad Prism 9.0を非線形フィッティングに使用し(図2に示すように、NIC吸入用量とラット死亡率の非線形フィッティング曲線である)。計算して得られたSDラットのNICエアロゾル吸入LC50値は37.8mg/kgであり、SDラットにおけるNICエアロゾル吸入のNOAEL用量は7.14mg/kg/dayであり、ヒト等価用量(HED)換算係数に従って計算されたヒト等価用量(HED)は1.13mg/kg/dayであった。 According to the statistics of inhaled dose and rat mortality, Graphpad Prism 9.0 was used for non-linear fitting (as shown in Figure 2, which is the non-linear fitting curve of NIC inhaled dose and rat mortality). The calculated LC50 value of NIC aerosol inhalation in SD rats is 37.8 mg/kg, and the NOAEL dose of NIC aerosol inhalation in SD rats is 7.14 mg/kg/day, converted to human equivalent dose (HED). The human equivalent dose (HED) calculated according to the coefficient was 1.13 mg/kg/day.
2.2ANA急性吸入毒性試験
曝露期間中の毒キャビネットのエアロゾル濃度、ANA吸入用量、および粒径分布を表2に示した。
2.2 ANA Acute Inhalation Toxicity Test The aerosol concentration, ANA inhalation dose, and particle size distribution of the poison cabinet during the exposure period are shown in Table 2.
臨床症状の観察:ANAエアロゾルの吸入用量はそれぞれ、174mg/kg、130mg/kg、87mg/kg、43.5mg/kgである場合、暴露中に死亡および瀕死の動物の割合はそれぞれ84.3%、52.0%、6.0%、1.5%に達した(図3に示すように、ANAエアロゾル吸入用量が174mg/kg、130mg/kg、87mg/kg、43.5mg/kgである場合に暴露中のラットの死亡率である)。死んでいない動物は試験終了まで14日間継続して観察され、異常な変化はなかった。 Observation of clinical symptoms: When the inhaled doses of ANA aerosol were 174 mg/kg, 130 mg/kg, 87 mg/kg, and 43.5 mg/kg, respectively, the proportion of dead and moribund animals during exposure was 84.3%, respectively. , 52.0%, 6.0%, and 1.5% (as shown in Figure 3, the ANA aerosol inhalation doses were 174 mg/kg, 130 mg/kg, 87 mg/kg, and 43.5 mg/kg). mortality rate of rats during exposure). Non-dead animals were observed continuously for 14 days until the end of the study and there were no abnormal changes.
吸入用量とラット死亡率結果の統計によると、Graphpad Prism 9.0を非線形フィッティングに使用し(図4に示すように、NIC吸入用量とラット死亡率結果の非線形フィッティング曲線である)、計算して得られたSDラットのANAエアロゾル吸入LC50値は125mg/kgであった。SDラットにおけるANAエアロゾル吸入のNOAEL用量は23.6mg/kg/dayであり、ヒト等価用量(HED)換算係数に従って計算されたヒト等価用量(HED)は3.75mg/kg/dayであった。 According to the statistics of inhalation dose and rat mortality results, Graphpad Prism 9.0 was used for nonlinear fitting (as shown in Figure 4, which is the nonlinear fitting curve of NIC inhalation dose and rat mortality results) and calculated. The obtained ANA aerosol inhalation LC50 value for SD rats was 125 mg/kg. The NOAEL dose of ANA aerosol inhalation in SD rats was 23.6 mg/kg/day, and the human equivalent dose (HED) calculated according to the human equivalent dose (HED) conversion factor was 3.75 mg/kg/day.
2.3亜急性毒性試験
暴露期間中の毒キャビネット内のANAエアロゾル吸入の最大用量はNOAEL(23.6mg/kg/day)であり、暴露あたり63分、1日1回で28日間続いた。エアロゾル濃度、ANA吸入用量および粒径分布を表3に示した。
2.3 Subacute Toxicity Test The maximum dose of ANA aerosol inhalation in the poison cabinet during the exposure period was NOAEL (23.6 mg/kg/day), lasting 28 days at 63 minutes per exposure and once a day. Aerosol concentration, ANA inhalation dose and particle size distribution are shown in Table 3.
亜急性吸入毒性:28日間の投与期間中、各用量群の雄および雌の試験ラットの体重変化を図5および6に示し(図5は、ANA亜急性毒性実験中の雄ラットの体重変化状況)、図6は、ANA亜急性毒性実験中の雌ラットの体重変化状況)、摂餌量の変化を図7および8に示し(図7はANA亜急性毒性実験中の雄ラットの摂餌量の変化を示し、図8はANA亜急性毒性実験中の雌ラットの摂餌量の変化を示している)、臓器重量の変化を表4、5に示した。 Subacute inhalation toxicity: The body weight changes of male and female test rats in each dose group during the 28-day administration period are shown in Figures 5 and 6. ), Figure 6 shows the change in body weight of female rats during the ANA subacute toxicity experiment), and Figures 7 and 8 show the changes in food intake (Figure 7 shows the change in food intake of male rats during the ANA subacute toxicity experiment). Figure 8 shows the changes in food intake of female rats during the ANA subacute toxicity experiment), and the changes in organ weights are shown in Tables 4 and 5.
図5~8および表4および5からわかるように、亜急性吸入毒性については、28日間の投与期間中、各用量群の雄と雌の試験ラット間で、体重、摂餌量、臓器重量などに統計的に有意な差はなかった(P>0.05)。 As can be seen from Figures 5 to 8 and Tables 4 and 5, subacute inhalation toxicity, including body weight, food intake, organ weight, etc., was observed between male and female test rats in each dose group during the 28-day administration period. There was no statistically significant difference (P>0.05).
気管支肺胞洗浄液
雌と雄の試験ラットの各用量群の気管支肺胞洗浄液中のAM(肺胞マクロファージ)、MONO(単球)、Lym(リンパ球)、Neut(好中球)、TP(総タンパク質)、ALP(アルカリホスファターゼ)、LDH(乳酸デヒドロゲナーゼ))などを検出し、対照群と比較して統計的差異はなかった(P>0.05)。試験データを表6および表7に示した。
Bronchoalveolar lavage fluid AM (alveolar macrophages), MONO (monocytes), Lym (lymphocytes), Neut (neutrophils), TP (total protein), ALP (alkaline phosphatase), LDH (lactate dehydrogenase)), etc., and there was no statistical difference compared to the control group (P>0.05). Test data are shown in Tables 6 and 7.
血液学指標
雄と雌の試験動物の異なる用量群の血液学的項目を検査したところ、各指標に有意差はなかった(P>0.05)、結果を表8および表9に示した。
Hematology Indices When the hematology parameters of different dose groups of male and female test animals were examined, there was no significant difference in each index (P>0.05), the results are shown in Tables 8 and 9.
組織病理学的検査
試験終了後、試験動物の組織をスライスし、肝臓、心臓、脾臓、肺臓、腎臓などの組織を染色して病理学的検査を実施し、結果を図9に示し、図9は、ANA試験動物の病理組織学的検査結果を示し、ここで、100倍の倍率、HE染色であり、図9からわかるように、対照群(sham control及びvehicle control)および高用量群(10%ANA)の動物組織には明らかな病理学的変化は見られなかった。
Histopathological examination After the test, the tissues of the test animals were sliced and the tissues of the liver, heart, spleen, lung, kidney, etc. were stained and subjected to pathological examination. The results are shown in Figure 9. shows the histopathological examination results of ANA test animals, where 100x magnification, HE staining, and control group (sham control and vehicle control) and high dose group (10x %ANA) No obvious pathological changes were observed in the animal tissues.
結論として、ラットの異なるグループ間で体重、摂餌量、臓器重量などに統計的に有意な差はなく(P>0.05)、血液、尿、気管支肺胞洗浄液、および組織病理学的検査では供試体に関連する異常な変化を示したものはなかった。 In conclusion, there were no statistically significant differences in body weight, food intake, organ weight, etc. between different groups of rats (P>0.05), and blood, urine, bronchoalveolar lavage fluid, and histopathological examination. None of the specimens showed any abnormal changes.
アナバシンとニコチンの吸入暴露毒性試験の結果を包括的に比較したところ、ヒトにおけるアナバシンの吸入耐性用量は3.75mg/kg/dayであり、NICへの吸入耐性用量は1.13mg/kg/dayであることがわかった。これは、アナバシンの生物毒性がニコチンよりも低く、電子送達製品でのアナバシンの使用がニコチンよりも生物学的安全性が高いことを示している。 A comprehensive comparison of the results of inhalation exposure toxicity studies of anabasine and nicotine showed that the inhalation tolerated dose of anabasine in humans is 3.75 mg/kg/day, and the inhalation tolerated dose for NIC is 1.13 mg/kg/day. It turned out to be. This indicates that the biotoxicity of anabasine is lower than that of nicotine and that the use of anabasine in electronic delivery products is more biologically safe than nicotine.
上記は、本発明の好ましい実施形態にすぎず、当業者にとって、本発明の原理から逸脱することなく、いくつかの改善および修正を行うことができ、これらの改善および修正も本発明の保護範囲と見なされるべきであることを指摘しておかなければならない。
The above are only preferred embodiments of the present invention, and those skilled in the art can make some improvements and modifications without departing from the principles of the present invention, and these improvements and modifications also fall within the protection scope of the present invention. It must be pointed out that it should be considered as
Claims (10)
充填物、接着剤、植物繊維を混合してパルプ化し、抄造してベースシートにするステップ(2)と、
前記ステップ(1)で得られたコーティング液を前記ステップ(2)で得られたベースシートにコーティングし、次に製紙法または乾式製紙法により固体フレークを得るステップ(3)と、を含み、
前記ステップ(1)と(2)は実行に順番がないことを特徴とする請求項3~8のいずれか一項に記載の固体フレークの製造方法。 a step (1) of mixing anabasine, a smoke agent, essence, and water to obtain a coating liquid;
Step (2) of mixing the filler, adhesive, and vegetable fibers, pulping them, and forming them into a base sheet;
Coating the base sheet obtained in step (2) with the coating liquid obtained in step (1), and then obtaining solid flakes by a papermaking method or a dry papermaking method (3),
The method for producing solid flakes according to any one of claims 3 to 8, characterized in that steps (1) and (2) are performed in no particular order.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210404390.3 | 2022-04-18 | ||
CN202210404390.3A CN114732148A (en) | 2022-04-18 | 2022-04-18 | Application of anabasine in heating non-combustion electron delivery product, solid-state slice and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2023158617A true JP2023158617A (en) | 2023-10-30 |
JP7436590B2 JP7436590B2 (en) | 2024-02-21 |
Family
ID=82281971
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022135290A Active JP7436590B2 (en) | 2022-04-18 | 2022-08-26 | Solid flakes and their manufacturing method |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP7436590B2 (en) |
CN (1) | CN114732148A (en) |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2009131646A (en) * | 2009-08-21 | 2011-03-10 | Юрий Владимирович Комиссаров (RU) | METHOD FOR CREATING AN ALKALOID-SMOKING SMOKE AND DEVICE FOR IMPLEMENTING THIS METHOD |
US20120325228A1 (en) | 2011-06-23 | 2012-12-27 | Williams Jonnie R | Alkaloid composition for e-cigarette |
CN103822992B (en) | 2014-03-16 | 2015-08-05 | 国家烟草质量监督检验中心 | The Gas Chromatographic Method of nicotine, myosmine, anabasine, anabasine and cotinine content in a kind of tobacco juice for electronic smoke |
KR102472348B1 (en) * | 2014-09-30 | 2022-12-01 | 필립모리스 프로덕츠 에스.에이. | Method for the production of homogenized tobacco material |
CN104705774B (en) * | 2015-01-28 | 2016-08-17 | 中国烟草总公司郑州烟草研究院 | A kind of preparation method of reconstituted tobacoo |
US20170112182A1 (en) | 2015-10-23 | 2017-04-27 | Next Generation Labs, LLC | Nicotine composition for vaping devices and vaping devices employing the same |
US11297876B2 (en) | 2017-05-17 | 2022-04-12 | Rai Strategic Holdings, Inc. | Aerosol delivery device |
CN108851192A (en) * | 2018-06-08 | 2018-11-23 | 湖北中烟工业有限责任公司 | The reconstituted tobacoo and production technology of the high porosity with minty note applied to low temperature cigarette |
CN108968165A (en) * | 2018-10-10 | 2018-12-11 | 湖北中烟工业有限责任公司 | A method of improving electronic cigarette and aspirates strength |
CN109393542A (en) * | 2018-11-21 | 2019-03-01 | 云南瑞升烟草技术(集团)有限公司 | A kind of preparation method for the low temperature coffee odor type cigarette material heating the cigarette that do not burn |
ES2956536T3 (en) | 2019-09-12 | 2023-12-22 | Cabbacis Llc | Articles and formulations for smoking and vaporizer products |
CN112931920A (en) * | 2019-11-26 | 2021-06-11 | 广东省金叶科技开发有限公司 | Non-tobacco heating non-combustion sheet and preparation method thereof |
EP4076023B1 (en) | 2019-12-18 | 2024-04-10 | Philip Morris Products S.A. | Method to produce a sheet of material containing alkaloids |
GB202006481D0 (en) | 2020-05-01 | 2020-06-17 | Exhale Tech Ltd | Composition and use thereof |
-
2022
- 2022-04-18 CN CN202210404390.3A patent/CN114732148A/en active Pending
- 2022-08-26 JP JP2022135290A patent/JP7436590B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN114732148A (en) | 2022-07-12 |
JP7436590B2 (en) | 2024-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2022519878A (en) | Filling material blended with aerosol-forming materials | |
CN113924005A (en) | Reconstituted cannabis material for aerosol generation | |
CN114269168A (en) | Reconstituted cocoa materials for aerosol generation | |
CN109090685A (en) | Cigarette shreds are not burnt in a kind of heating and heating prepared therefrom is not burnt cigarette | |
CN104397871A (en) | Electronic cigarette liquid containing tea extracts and preparation method of electronic cigarette liquid containing tea extracts | |
CN108576912A (en) | The reconstituted tobacoo and its production technology of a kind of metal-containing powders applied to low temperature cigarette | |
CN109463795A (en) | A kind of fragrant Matrix formulation procedure of extrusion forming smoke production for induction heating | |
JP2021129549A (en) | High smoke granule used in heat non-combustion product as well as preparation method and usage thereof | |
CN104970445B (en) | A kind of spacetabs type aerosol mouth cigarette | |
CN111920079A (en) | Electronic atomization inhalant and preparation method thereof | |
CN113784632A (en) | High-density reconstituted plant sheet | |
CN106723304A (en) | Clove leaf non-tobacco cigarette and preparation method thereof | |
US20050263165A1 (en) | Tobacco leaf substitute | |
JP7436590B2 (en) | Solid flakes and their manufacturing method | |
CN113662234A (en) | Antibacterial atomized liquid and preparation method thereof | |
CN106723307A (en) | Folium Taraxacum non-tobacco cigarette and preparation method thereof | |
CN112931920A (en) | Non-tobacco heating non-combustion sheet and preparation method thereof | |
CN109602068A (en) | Plantflakesare, cigarette substitute and preparation method thereof and cigarette | |
US20040094170A1 (en) | Nicotine free cigarette substitute | |
JP7436587B2 (en) | Atomizing solutions used in atomized electronic delivery products | |
CN108420124A (en) | A kind of low temperature cigarette and preparation method thereof with pungent fragrant loose integrated tobacco segment | |
JP2019187395A (en) | Electronic cigarette liquid | |
CN103892437A (en) | Novel tobacco production method | |
CN1206947C (en) | Formulating method of felon herb aspiration product | |
CN106820249A (en) | Folium isatidis non-tobacco cigarette and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220827 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220902 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230718 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20231018 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231215 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240123 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240208 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7436590 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |